# Articaine HCL and Epinephrine (articaine hydrochloride and epinephrine bitartrate) by Aira LLC: new human prescription drug listing

**Launch Signal Score:** 75/100

| Field | Value |
|---|---|
| Product | Articaine HCL and Epinephrine |
| Generic name | articaine hydrochloride and epinephrine bitartrate |
| NDC | 87566-110 |
| Labeler | Aira LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | NDA AUTHORIZED GENERIC |
| Application number | NDA022466 |
| Dosage form | INJECTION |
| Route | SUBMUCOSAL |
| Active ingredients | ARTICAINE HYDROCHLORIDE 40 mg/mL; EPINEPHRINE BITARTRATE 10 ug/mL |
| Marketing start | 2026-09-15 |
| Package configurations | 1 |

## Why this score
- Prescription or biologic product.
- New generic entry: wholesalers and GPOs re-bid contracts.
- Injectable: hospital and 503B relevance.

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=87566-110). Last refreshed: 2026-11-03T18:09:00.764Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.